Altered vascular phenotype in autism: Correlation with oxidative stress

Archives of Neurology

Volumn 63, Issue 8, 2006, Pages 1161-1164

  Yao, Yuemang ^a   Walsh, William J ^b   McGinnis, Woody R ^c   Praticò, Domenico ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Pfeiffer Treatment Center   (United States)

^c John Morgan Building ^*

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DINORTHROMBOXANE B2; 6 OXOPROSTAGLANDIN F1 ALPHA; ISOPROSTANE DERIVATIVE; ISOPROSTANE F2ALPHA; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; URINALYSIS; VASCULAR ENDOTHELIUM;

AUTISTIC DISORDER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PHENOTYPE; PLATELET ACTIVATION;

EID: 33747202981     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.8.1161     Document Type: Article

References (22)

1. Eigsti IM, Shapiro T. A systems neuroscience approach to autism: biological, cognitive, and clinical perspectives. Ment Retard Dev Disabil Res Rev. 2003;9:205-215.
2. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA. 2003;289:49-55.
3. Bauman ML, Kemper TL. The neuropathology of the autism spectrum disorders: what have we learned? Novartis Found Symp. 2003;251:112-122.
4. Korvatska E, Van de Water J, Anders TF, Gershwin ME. Genetic and immunologic considerations in autism. Neurobiol Dis. 2002;9:107-125.
5. Newschaffer CJ, Fallin D, Lee NL. Heritable and nonheritable risk factors for autism spectrum disorders. Epidemiol Rev. 2002;24:137-153.
6. Sogut S, Zoroglu SS, Ozyurt H, et al. Changes in nitric oxide levels and antioxidant activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta. 2003;331:111-117.
7. Filipek PA, Juranek J, Nguyen MT, Cummings C, Gargus JJ. Relative carnitine deficiency in autism. J Autism Dev Disord. 2004;34:615-623.
8. James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004;80:1611-1617.
9. Chauhan A, Chauhan V, Brown WT, Cohen I. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins. Life Sci. 2004;75:2539-2549.
10. Ming X, Stein TP, Brimacombe M, Johnson WG, Lambert GH, Wagner GC. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids. 2005;73:379-384.
11. Praticò D, Lawson JA, Rokach J, FitzGerald GA. The isoprostanes in biology and medicine. Trends Endocr Metabol. 2001;12:243-247.
12. Safai-Kutti S, Kutti J, Gillberg C. Impaired in vivo platelet reactivity in infantile autism. Acta Paediatr Scand. 1985;74:799-800.
13. Praticò D, Cyrus T, Li H, FitzGerald GA. Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis. Blood. 2000;96:3823-3826.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
15. Lord C, Pickles A, McLennan J, et al. Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord. 1997;27:501-517.
16. Ding T, Yao Y, Praticò D. Increase in peripheral oxidative stress during hypercholesterolemia is not reflected in the central nervous system: evidence from two mouse models. Neurochem Int. 2005;46:435-439.
17. Cyrus T, Sung S, Zhao L, Funk CD, Tang S, Praticò D. Effect of low-dose aspirin on vascular inflammation, plaque stability and atherogenesis in low-density lipoprotein receptor deficient mice. Circulation. 2002;106:1282-1287.
18. Dolske MC, Spollen J, McKay S, Lancashire E, Talbert L. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17:765-774.
19. Yorbik O, Sayal A, Akay C, Akbiyik DI, Sohmen T. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids. 2002;67:341-343.
20. Zoroglu SS, Armutcu F, Ozen S, et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci. 2004;254:143-147.
21. Boddaert N, Zilbovicius M. Functional neuroimaging and childhood autism. Pediatr Radiol. 2002;32:1-7.
22. Wilcox J, Tsuang MT, Ledger E, Algeo J, Schnurr T. Brain perfusion in autism varies with age. Neuropsychobiology. 2002;46:13-16.